Latest Rock Creek Pharmaceutical Stories
Provides European Drug Development Strategy Update SARASOTA, Fla., Dec.
SARASOTA, Fla., Dec.
SARASOTA, Fla., Nov.
SARASOTA, Fla., Aug.
SARASOTA, Fla., July 31, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced today that it has initiated the development of its lead molecule, Anatabine Citrate,
GLEN ALLEN, Va., June 2, 2014 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) announced that the Company will formally change its corporate name to Rock Creek Pharmaceuticals, Inc.
GLEN ALLEN, Va., April 7 /PRNewswire-FirstCall/ -- Star Scientific (Nasdaq: CIGX) announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease.
PETERSBURG, Va., Jan. 6 /PRNewswire-FirstCall/ -- Star Scientific (Nasdaq: STSI) announced today that its subsidiary, Rock Creek Pharmaceuticals, Inc., in conjunction with its Star Tobacco, Inc.
- A poem in which the author retracts something said in an earlier poem.